Xlife Sciences AG (SWX:XLS)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
20.50
-0.10 (-0.49%)
Last updated: May 13, 2026, 3:11 PM CET
Market Cap118.81M -20.4%
Revenue (ttm)275.31K -67.0%
Net Income-21.55M
EPS-3.76
Shares Out5.77M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume780
Average Volume3,718
Open20.60
Previous Close20.60
Day's Range20.40 - 20.60
52-Week Range15.75 - 26.80
Beta0.42
RSI44.00
Earnings DateApr 28, 2026

About Xlife Sciences AG

Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company’s project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data. It also produces, researches, develops, and manufactures the chemical and active pharmaceutical ingredients for human and veterinary medicines; and offers clinical resea... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2019
Employees 17
Stock Exchange SIX Swiss Exchange
Ticker Symbol XLS
Full Company Profile

Financial Performance

Financial Statements